Kalbe Farma Balance Sheet Health
Financial Health criteria checks 6/6
Kalbe Farma has a total shareholder equity of IDR23,911.7B and total debt of IDR715.4B, which brings its debt-to-equity ratio to 3%. Its total assets and total liabilities are IDR28,751.8B and IDR4,840.0B respectively. Kalbe Farma's EBIT is IDR3,989.5B making its interest coverage ratio -40.7. It has cash and short-term investments of IDR4,316.4B.
Key information
3.0%
Debt to equity ratio
Rp715.39b
Debt
| Interest coverage ratio | -40.7x |
| Cash | Rp4.32t |
| Equity | Rp23.91t |
| Total liabilities | Rp4.84t |
| Total assets | Rp28.75t |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: LCLA's short term assets (IDR17,032.6B) exceed its short term liabilities (IDR4,104.8B).
Long Term Liabilities: LCLA's short term assets (IDR17,032.6B) exceed its long term liabilities (IDR735.3B).
Debt to Equity History and Analysis
Debt Level: LCLA has more cash than its total debt.
Reducing Debt: LCLA's debt to equity ratio has reduced from 4.5% to 3% over the past 5 years.
Debt Coverage: LCLA's debt is well covered by operating cash flow (692.8%).
Interest Coverage: LCLA earns more interest than it pays, so coverage of interest payments is not a concern.